ALISHA MORRIS: Open Payments
NPI 1558806646 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,199 in 94 payments from 25 companies in 2025. Trend: 2023 $2,702 · 2024 $1,632 · 2025 $2,199
Food & beverage: $2,093Education: $105
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 25 | $677 |
| Regeneron Healthcare Solutions, Inc. | 11 | $281 |
| GlaxoSmithKline, LLC. | 15 | $275 |
| Otsuka America Pharmaceutical, Inc. | 1 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $108 |
| GENZYME CORPORATION | 4 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $57 |
| Electromed, Inc. | 2 | $55 |
| Amgen Inc. | 3 | $53 |
| CSL Behring | 3 | $52 |
Products named: DUPIXENT, FASENRA, TEZSPIRE, NUCALA, BREZTRI, REXULTI, TRELEGY ELLIPTA, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
